GE HealthCare, a subsidiary of General Electric, is a leading player in the global healthcare industry, headquartered in the United States. Founded in 1892, the company has evolved significantly, marking key milestones such as the introduction of advanced imaging technologies and innovative patient monitoring systems. With a strong presence in North America, Europe, and Asia, GE HealthCare focuses on medical imaging, monitoring, biomanufacturing, and digital solutions. Its core products, including MRI machines, ultrasound systems, and healthcare IT solutions, are renowned for their cutting-edge technology and reliability. As a pioneer in healthcare innovation, GE HealthCare has consistently maintained a strong market position, recognised for its commitment to improving patient outcomes and operational efficiency in healthcare settings worldwide.
How does GE HealthCare's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
GE HealthCare's score of 81 is higher than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, GE HealthCare reported significant carbon emissions, totalling approximately 10,500,000,000 kg CO2e for Scope 1, 11,600,000,000 kg CO2e for Scope 2, and a staggering 6,064,000,000,000 kg CO2e for Scope 3 emissions. This reflects a comprehensive approach to emissions reporting, covering all three scopes. In comparison, the 2023 figures showed Scope 1 emissions at about 11,500,000,000 kg CO2e, Scope 2 at approximately 12,400,000,000 kg CO2e, and Scope 3 at around 6,349,000,000,000 kg CO2e. GE HealthCare has set ambitious climate commitments, aiming to achieve net zero greenhouse gas emissions across its value chain by 2050. The company has established interim targets to reduce absolute Scope 1 and 2 emissions by 42% by 2030 from a 2022 baseline, and to cut Scope 3 emissions from purchased goods and services, upstream transportation, and business travel by 25% by the same year. Additionally, at its largest chemical manufacturing site in Uppsala, Sweden, GE HealthCare aims for a 30% reduction in carbon dioxide emissions by 2030. These targets are aligned with the Science Based Targets initiative (SBTi), which has classified GE HealthCare's near-term targets as consistent with limiting global warming to 1.5°C. The company is committed to reducing its absolute Scope 1, 2, and 3 emissions by 90% by 2050 from a 2022 baseline, demonstrating a robust commitment to sustainability and climate action.
Access structured emissions data, company-specific emission factors, and source documents
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|
Scope 1 | 1,670,000,000 | 0,000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000,000 | 000,000,000,000 | 000,000,000,000 |
Scope 2 | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000,000 | 000,000,000,000 |
Scope 3 | 2,790,000,000 | 0,000,000,000 | - | - | - | 0,000,000,000,000 | 0,000,000,000,000 | 0,000,000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
GE HealthCare is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.